相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring the origins of grey matter damage in multiple sclerosis
Massimiliano Calabrese et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
Nicola De Stefano et al.
CNS DRUGS (2014)
Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model
Michael G. Dwyer et al.
NEUROIMAGE (2014)
Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing-Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
Robert Zivadinov et al.
PLOS ONE (2014)
Preventing brain atrophy should be the gold standard of effective theraphy in MS (after the first year of treatment): No
M. Filippi et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
Angela Vidal-Jordana et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Clinical correlates of grey matter pathology in multiple sclerosis
Dana Horakova et al.
BMC NEUROLOGY (2012)
Clinical applications of imaging disease burden in multiple sclerosis: MRI and advanced imaging techniques
Claire Riley et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: Results of a five-year brain MRI study
Omar Khan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Measurement and clinical effect of grey matter pathology in multiple sclerosis
Jeroen J. G. Geurts et al.
LANCET NEUROLOGY (2012)
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis
F. Rinaldi et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
A case of multiple sclerosis presenting with inflammatory cortical demyelination
B. F. Gh. Popescu et al.
NEUROLOGY (2011)
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
Massimiliano Calabrese et al.
ARCHIVES OF NEUROLOGY (2009)
IFN-β Inhibits Human Th17 Cell Differentiation
Vinod S. Ramgolam et al.
JOURNAL OF IMMUNOLOGY (2009)
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis
Ij van den Elskamp et al.
MULTIPLE SCLEROSIS (2008)
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
R. Zivadinov et al.
NEUROLOGY (2008)
Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis
Bianca Weinstock-Guttman et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial
H Panitch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis
MP Sormani et al.
NEUROLOGY (2004)
Interferon-β-1b slows progression of atrophy in RRMS -: Three-year follow-up in NAb- and NAb+ patients
JA Frank et al.
NEUROLOGY (2004)
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis
R Zivadinov et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules:: a critical role for P-selectin glycoprotein ligand-1
L Battistini et al.
BLOOD (2003)
Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years
B Turner et al.
MULTIPLE SCLEROSIS (2003)
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
L Bo et al.
MULTIPLE SCLEROSIS (2003)
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with interferon-beta
A Paolillo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-Ia
C Gasperini et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
Brain atrophy in clinically early relapsing-remitting multiple sclerosis
DT Chard et al.
BRAIN (2002)
Short-term brain volume change in relapsing-remitting multiple sclerosis - Effect of glatiramer acetate and implications
M Rovaris et al.
BRAIN (2001)
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson et al.
ANNALS OF NEUROLOGY (2001)
A longitudinal study of ventricular volume in early relapsing-remining multiple sclerosis
TL Luks et al.
MULTIPLE SCLEROSIS (2000)
Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
H Babbe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A longitudinal study of T1 hypointense lesions in relapsing MS -: MSCRG trial of interferon β-1a
JH Simon et al.
NEUROLOGY (2000)
Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS - Quantitative MR assessment
Y Ge et al.
NEUROLOGY (2000)
New variants of a method of MRI scale standardization
LG Nyúl et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2000)
分享论文
